Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)
China · Delayed Price · Currency is CNY 39.08
+0.70 (1.82%)
Apr 14, 2026, 3:00 PM CST
SHA:603392 Market Cap
SHA:603392 has a market cap or net worth of 49.41 billion as of April 14, 2026. Its market cap has decreased by -43.15% in one year.
Market Cap
49.41B
Enterprise Value
44.84B
Revenue
1.80B
Ranking
n/a
PE Ratio
n/a
Stock Price
39.08
Market Cap Chart
Since April 29, 2020, SHA:603392's market cap has increased from 5.46B to 49.41B, an increase of 804.43%. That is a compound annual growth rate of 44.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 48.53B | -14.60% |
| Dec 31, 2025 | 56.82B | -36.26% |
| Dec 31, 2024 | 89.14B | -6.44% |
| Dec 29, 2023 | 95.28B | -17.00% |
| Dec 30, 2022 | 114.80B | -14.62% |
| Dec 31, 2021 | 134.46B | 53.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Haisco Pharmaceutical Group | 67.25B |
| Sunshine Guojian Pharmaceutical (Shanghai) | 52.83B |
| Pharmaron Beijing | 51.70B |
| Shanghai Allist Pharmaceuticals | 43.19B |
| Asymchem Laboratories (Tianjin) | 42.57B |
| Hebei Changshan Biochemical Pharmaceutical | 40.78B |
| Shanghai RAAS Blood Products | 37.24B |
| Chongqing Zhifei Biological Products | 37.06B |